Understanding Mitochondrial Dysfunction & Enhancing Mitochondria- Targeted Research whilst Advancing Therapeutics for Mitochondrial & Age-related Diseases

Join 80+ of the leading experts in targeting mitochondria, including Stealth BioTherapeutics, Cohbar, GenSight Biologics, Minovia Therapeutics and MISSION Therapeutics as they drive towards a better understanding of how to best optimize and improve the persistence and durability of effective and scalable mitochondrial therapies for chronic acquired age-related and rare genetic mitochondrial diseases.

This summit is your only and definitive meeting to examine the advancement of innovative therapies and drugs, focusing on the latest research in innovative targeting pathways, unique therapeutics, and new techniques to target mitochondrial dysfunction, whilst evaluating your clinical development landscape.

Incorporating insights from leading academics and pioneering biotech, uncover innovative research whilst gaining extensive technical knowledge on mitochondria-targeted therapies.

  • Explore how to overcome challenges with evaluating compounds and securing approval in various diseases affected by mitochondria dysfunction.
  • Understand difficulties with biomarkers of mitochondria and levels of mitochondria per cell.

Thank you to our speakers, sponsors, and delegates who joined us for the online summit! If you are interested in the 2022 event, please get in touch at info@hansonwade.com. 

"The quality of the attendees and the speakers were outstanding. The speakers were exceptional, I was blown away. I’m still trying to recover"
CEO & CFO, Bach Pharma


"The expertise of the speakers and the range of topics was impressive for a small meeting. The size of the meeting facilitated extensive discussions among the speakers and participants"
Director, Toxicology, Biogen


"Several presentations and discussions with upcoming talents in the life sciences"
Chief Scientific Officer, TeneoBio

Among the Expert Speaker Faculty

Barry Bochner

President, CEO & CSO

Biolog, Inc.

Douglas Wallace

Michael & Charles Barnett Endowed Chair | Director | Professor

Pediatric Mitochondrial Medicine & Metabolic Disease | Center for Mitochondrial & Epigenomic Medicine | University of Pennsylvania

Mike Murphy

Principal Investigator, MRC Mitochondrial Biology Unit

University of Cambridge

Reenie McCarthy

Chief Executive Officer

Stealth BioTherapeutics

Proud to Partner with:

Media Partners: